Glenn Pacheco

955 total citations
11 papers, 610 citations indexed

About

Glenn Pacheco is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Glenn Pacheco has authored 11 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Glenn Pacheco's work include Angiogenesis and VEGF in Cancer (3 papers), Occupational and environmental lung diseases (3 papers) and MRI in cancer diagnosis (2 papers). Glenn Pacheco is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Occupational and environmental lung diseases (3 papers) and MRI in cancer diagnosis (2 papers). Glenn Pacheco collaborates with scholars based in United States, Netherlands and United Kingdom. Glenn Pacheco's co-authors include Sarajane Ross, Franklin Peale, Sharon Yee, Joe Kowalski, Gregory D. Plowman, Anil Bagri, Marc Tessier‐Lavigne, Wei‐Ching Liang, Yvan H. Chanthery and Yan Wu and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Cell and Cancer Research.

In The Last Decade

Glenn Pacheco

11 papers receiving 594 citations

Peers

Glenn Pacheco
Jennifer L. Gilmore United States
Sheila Bheddah United States
Petr Bušek Czechia
Monique Dail United States
Amy Jackson-Fisher United States
Alessia Bottos Switzerland
Melinda D. Willard United States
Glenn Pacheco
Citations per year, relative to Glenn Pacheco Glenn Pacheco (= 1×) peers Zhiyong Cheng

Countries citing papers authored by Glenn Pacheco

Since Specialization
Citations

This map shows the geographic impact of Glenn Pacheco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Pacheco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Pacheco more than expected).

Fields of papers citing papers by Glenn Pacheco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Pacheco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Pacheco. The network helps show where Glenn Pacheco may publish in the future.

Co-authorship network of co-authors of Glenn Pacheco

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Pacheco. A scholar is included among the top collaborators of Glenn Pacheco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Pacheco. Glenn Pacheco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Agrawal, Vishal, Glenn Pacheco, Alessandra d’Azzo, et al.. (2020). Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency. Journal of Biological Chemistry. 295(39). 13556–13569. 9 indexed citations
3.
Berguig, Geoffrey Y., Nathan Martin, Lin Xie, et al.. (2019). Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain. Molecular Genetics and Metabolism. 128(4). 422–430. 15 indexed citations
4.
Scheltinga, Anton G.T. Terwisscha van, Annie Ogasawara, Glenn Pacheco, et al.. (2016). Preclinical Efficacy of an Antibody–Drug Conjugate Targeting Mesothelin Correlates with Quantitative 89Zr-ImmunoPET. Molecular Cancer Therapeutics. 16(1). 134–142. 33 indexed citations
5.
Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models. Molecular Cancer Therapeutics. 13(11). 2630–2640. 52 indexed citations
6.
Kamath, Amrita V., Victor Yip, Priyanka Gupta, et al.. (2014). Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice. mAbs. 6(6). 1631–1637. 15 indexed citations
7.
Scales, Suzie J., Nidhi Gupta, Glenn Pacheco, et al.. (2014). Abstract 4494: A clinical candidate anti-mesothelin-MMAE antibody-drug conjugate (ADC) for therapy of mesothelin-expressing cancers. Cancer Research. 74(19_Supplement). 4494–4494. 1 indexed citations
8.
Gupta, Nidhi, Willy A. Solis, Reina N. Fuji, et al.. (2014). Abstract 4502: Nonclinical characterization and tolerability of a surrogate anti-mesothelin-MMAE antibody-drug conjugate. Cancer Research. 74(19_Supplement). 4502–4502. 1 indexed citations
9.
Pacheco, Glenn, Calvin Ho, Sharon Yee, et al.. (2011). Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magnetic Resonance in Medicine. 65(3). 889–899. 11 indexed citations
10.
Pacheco, Glenn, Calvin Ho, Sharon Yee, et al.. (2010). Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magnetic Resonance in Medicine. 63(6). 1637–1647. 43 indexed citations
11.
Pan, Qi, Yvan H. Chanthery, Wei‐Ching Liang, et al.. (2007). Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth. Cancer Cell. 11(1). 53–67. 425 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026